(Feb 28): Life science innovations have led to significant breakthroughs in healthcare and other sectors over the past decade. This has caught the attention of investors seeking alternative sources of returns in a low-yield and highly volatile market environment. 

Xeraya Capital, a wholly-owned PE and venture capital entity of Khazanah Nasional, Malaysia’s sovereign wealth fund, is currently looking to raise US$400 million ($559 million) for its fourth life sciences fund. The Xeraya Opportunities Fund (XoF) is expected to reach its final close in the next two years, says Xeraya CEO Fares Zahir. 

“This fund is built on a model of capturing global investments in key critical areas such as oncology, cardiovascular therapies and infectious diseases. We also see opportunities in artificial intelligence-related healthcare solutions. In fact, we have invested in this area in the past. So, the fund will be looking at this as well. We are also looking at things related to food security. 

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook